Macular Edema clinical trials

Explore recruiting macular edema clinical trials.

Recruiting macular edema studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Macular Edema trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A RANDOMIZED, DOUBLE-MASKED, MULTI-CENTER, 3-ARM PHASE 2/3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF INTRAVITREAL EYE103 COMPARED WITH INTRAVITREAL RANIBIZUMAB (0.5MG) IN PARTICIPANTS WITH DIABETIC MACULAR EDEMA

Italy, Germany, Latvia, Hungary, France, Czechia +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

A phase IV study of Faricimab to explore associations of visual acuity benefits and changes in vascular integrity using adaptive optics in patients with diabetic macular edema

Germany

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Double-masked, Multi-center, 3-Arm Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal EYE103 Compared with Intravitreal ranibizumab (0.5mg) in Participants with Diabetic Macular Edema

Italy, Spain, Slovakia, Poland, Portugal, Croatia +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2/3 Double-masked, Randomized, 2-stage, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

Spain, Hungary

Phase II and Phase III (Integrated) EU CTIS Study details

A Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea High Dose (HD) in Participants with Diabetic Macular Edema (ALVOEYE-HD)

Latvia, Slovakia, Czechia, Hungary, Poland, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized clinical two-arm trial comparing inflammation and cystoid macular edema for the medication regimens postoperative topical NSAIDs and steroids to only postoperative topical steroids in patients undergoing corneal endothelial transplantations (DMEC).

Norway

Therapeutic use (Phase IV) EU CTIS Study details

Macular Edema trials by city

Macular Edema in Toronto Macular Edema in Vancouver Macular Edema in Montreal Macular Edema in Calgary Macular Edema in Edmonton Macular Edema in Ottawa Macular Edema in Winnipeg Macular Edema in Quebec City Macular Edema in Hamilton Macular Edema in Kitchener Macular Edema in London Macular Edema in Halifax Macular Edema in New York Macular Edema in Los Angeles Macular Edema in Chicago Macular Edema in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease